Navigation Links
Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study

ange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events, or otherwise.

About Novartis
Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.
References
[1] Mochizuki S et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
2. Tekturna, First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
9. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus

Post Your Comments:
(Date:11/20/2009)... , HARRISBURG, Pa., Nov. 20 /PRNewswire-USNew...viding free H1N1 flu shots to members of priority ...ccine. ,, A total of 18 clinics are being held ... from 2 p.m. to 8 p.m. Hours on Saturday, Nov. 21,...clinics will operate from 2 p.m. to 8 p.m. ,, ...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Repor...eport is available in its catalogue. ,, Global...easing Adoption to Drive Growth ,, http://ww...-Blood-Glucose-Market-(SMBG )-Increasing-Adoption-..._medium=pr&utm_campaign=prnewswire ,, Des...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ,...earch report is available in its catalogue. ,, ...asts to 2015 ,, http://www.reportlinker.com/...nd-Forecasts-to-2015.html#utm_source=prnewswire&am..., Description ,, India Medical Equipment Mark...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13RadMD Offers Tips on Optimizing Clinical Trial Efficiency 5741 1RadMD Offers Tips on Optimizing Clinical Trial Efficiency 5741 2RadMD Offers Tips on Optimizing Clinical Trial Efficiency 5741 3Elsevier introduces Aesthetic Plastic Surgery 60149 1Elsevier introduces Aesthetic Plastic Surgery 60149 2The skeleton 3A Size matters 10538 1The skeleton 3A Size matters 10538 2
... Weekly Investigational Diabetes Therapy Also Impr...m Exenatide Taken Twice a Day, SAN FRANCISCO, Jun... Eli Lilly and Company (NYSE: LLY ), and Alkermes...om a 52-week open-label clinical,study that showed...long-acting release formulation of exenatide. Pati...
...O, June 9 Two long-term, large-scale and,independ...s in people with,type 2 diabetes enrolled more tha...maleate) and provide more than 20,000 patient year...ans Affairs Diabetes Trial,(VADT), through two sep...om,VADT, there is no evidence to suggest that use ...
Other Medicine Technology:After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 2Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 3Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 4
(Date:11/21/2009)... New Haven Dental Group merges their practi...rd, CT. , (PRWEB) Novembe...d of partners Dr. David Gibson, Dr. Dean Cloutier,...ust merged their growing practice with that of est.... Pickman decided he wanted to retire from dentist...
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)..., Nov. 20 The American ... and Drug Administration (FDA) to establish approp...s. ,, Citing concern about the safety of white...the benefit of professional consultation or examin...application of chemically based tooth whitening or...
(Date:11/20/2009)...-SALEM, N.C., Nov. 20 S...on to redefine what it means to be "happy" during ... with a specialty in family counseling and chair o...ersity, Gladding says research shows that it is th... and even depression during the holidays. ,, Th...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...multi-disciplinary team of scientists from the Uni...he way for the development of a powerful new strat...prostate cancer. , The research is to use cuttin...rchers say that microscopic (5-100 nm) magnetic na...
...finds that enforcing existing laws cuts rate by 21...y News) -- American adolescents who live in states...ly to pick up a smoking habit than are those who l...ater, effect, the study also showed. , "Efforts to...
...ressional Members Address Negative Impacts of the ... Letter to the White House & Department of Hea...In a letter sent yesterday, a bipartisan group of ...lth and Human Services to review and rescind the c...
...GAAP Operating Loss Improves by 55% to $19.9 Milli...in/Lilly Alliance Restructures Exenatide Operation... April 16 Amylin Pharmaceuticals, Inc. (Nasdaq: ...ded March 31, 2009, which includes net product sal...
...ng registration critical to solving shortages, exp... News) -- Most Americans say they want to donate t...rs are registered to do so, a new survey shows. , ...,100 U.S. adults conducted in February by Astellas...
...BASAS, Calif., April 16 With so many people out o... for Social Security Disability Insurance (SSDI). ...ctory website to help people with disabilities to ...and take any job they can find. But, with fewer jo...
Other Medicine News:Health News:Pioneering medical nanotechnology offers new cancer breakthrough hope 2Health News:Tough Laws, Higher Prices Mean Fewer Kids Smoke 2Health News:Tough Laws, Higher Prices Mean Fewer Kids Smoke 3Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 2Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 3Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 4Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 5Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 2Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 3Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 4Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 5Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 6Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 7Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 8Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 9Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 10Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 11Health News:Survey Shows Many Want to Donate Organs, But Few Do 2Health News:Social Security Attorney Directory Helps to Speed SSDI Benefits 2
...deo into the digital age to document surgical proc...e standard surgical video cart, the SOLOS Digital ... to document and archive surgical and diagnostic i...nce, referrals, teaching and training. The DIS2000...
...ision Autoclavable 3CCD Camera Head utilizes Linva...re true autoclavability. Incorporating the durabil...customers the extra protection needed to protect t...y optic, which optimizes image quality while elimi...
...era Systems provide the advanced functionality and...ced training. Programmable, easy to activate "Pres...ccommodate the imaging demands of all endoscopic s...non-autoclavable camera heads, the new IM3200 seri...
...ystem provides easy-to-use features, auto iris, wh...a head construction is based on Solos durable ligh...System, Domestic (GS 9900-NTSC) includes: , (GS 99...video cables , (GS 9904) Camera head with 3 meter ...
Medicine Products: